← Eichor
Condition: Staphylococcus Aureus Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Staphylococcus Aureus

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial
Phase 4 · 1 location(s) · Frieder Schaumburg · NCT05899140Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia
Phase 4 · 1 location(s) · Todd C. Lee MD MPH FIDSA · NCT06650488Effectiveness of Screening and Decolonization of S. Aureus to Prevent S. Aureus Surgical Site Infections in Surgery Outp
Phase N/A · 1 location(s) · University of Minnesota · NCT06378359Prodromes of Menstrual Staphylococcal Toxic Shock
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT06124599Identification and Validation of Clinical Phenotypes in Staphylococcus Aureus Bacteremia and Their Association With Mort
Phase N/A · 1 location(s) · Fundación Pública Andaluza para la gestión de la Investigaci · NCT06574399Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome
Phase 1 · 1 location(s) · Johns Hopkins University · NCT06283355Dalbavancin Versus Standard Antibiotic Therapy for Catheter-related Bloodstream Infections Due to Staphylococcus Aureus
Phase 3 · 2 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05117398Linezolid Plus Standard of Care
NA · 12 location(s) · University Hospital, Basel, Switzerland · NCT06958835First-in-man Single-dose and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy ofHY-133
Phase 1 · 2 location(s) · University Hospital Tuebingen · NCT06290557Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia
Phase 2 · 6 location(s) · Todd C. Lee MD MPH FIDSA · NCT04886284Study of the Nasal Intracellular Reservoir of Staphylococcus Aureus in Patients With S. Aureus Bacteremia
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT06594250Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP
Phase 4 · 1 location(s) · University of Virginia · NCT05094570NAsal MEthicillin-resistant Staphylococcus (NAMES): a Prospective Study to Assess the Impact of Antibiotic Therapy on Na
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT06872099Rapid De-escalation of Anti-MRSA Therapy Guided by S. Aureus Nares Screening in Case of Pneumonia
NA · 1 location(s) · University of Bari Aldo Moro · NCT06238297Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia
Phase 4 · 1 location(s) · Region Skane · NCT06726395Evaluating Simplified Layered Consent for Clinical Trials
NA · 6 location(s) · Sunnybrook Health Sciences Centre · NCT06168474Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections
Phase 4 · 1 location(s) · Indiana University · NCT06982105A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Dis
Phase 1/Phase 2 · 43 location(s) · AstraZeneca · NCT06749457Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment in
Phase 2 · 1 location(s) · University Hospital, Basel, Switzerland · NCT05655091Staphylococcus Aureus Network Adaptive Platform Trial
Phase 4 · 161 location(s) · University of Melbourne · NCT05137119Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia
Phase 4 · 18 location(s) · Todd C. Lee MD MPH FIDSA · NCT06637332Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment
Phase 1 · 1 location(s) · Johns Hopkins University · NCT06805994Rifampin-free Regimen Versus Rifampin-containing Regimen in the Treatment of Staphylococcal Prosthetic Valve Endocarditi
Phase 3 · 31 location(s) · Nantes University Hospital · NCT07345325International Surveillance of Antimicrobial Resistance in Cirrhosis-Related Infections
Phase N/A · 1 location(s) · Hospital Italiano de Buenos Aires · NCT06634940NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT05017766Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia
Phase 4 · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT06650501Early Intravenous to Oral Antibiotic Switch in Uncomplicated Staphylococcus Aureus Bacteraemia
Phase 3 · 12 location(s) · Clinical Research Centre, Malaysia · NCT06336824Echocardiography Versus no Echocardiography in S. Aureus Bacteraemia and VIRSTA Score < 3
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06457386A Study to Evaluate the Safety and Pharmacokinetics of AZD7760 in Healthy Japanese Adults
Phase 1 · 1 location(s) · AstraZeneca · NCT07612813Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus
Phase 3 · 1 location(s) · Todd C. Lee MD MPH FIDSA · NCT07253688
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.